Together we can end breast cancer.

by Lynn Sage Breast Cancer Foundation
Play Video
Together we can end breast cancer.
Together we can end breast cancer.
Together we can end breast cancer.
Together we can end breast cancer.
Together we can end breast cancer.
Together we can end breast cancer.
Together we can end breast cancer.

Project Report | Dec 4, 2019
Preliminary success of a Lynn Sage Scholar

By Angie Fekrat | Executive Director

Dr. Horiuchi in Lab
Dr. Horiuchi in Lab

“We could not be more grateful for the support that The Lynn Sage Foundation has provided to us over the past two years,” comments prior Lynn Sage Scholar Dr. Horiuchi. 

His Lynn Sage Scholar award period concluded at the end of June 2019.  The theory he pursued, that the S100 family of calcium-binding proteins correlated with poor outcomes in Triple Negative Breast Cancer (TNBC) patients, was initially considered ambitious.  It could not have been considered for funding by federal sources at the time of his initial award.  Dr. Horiuchi knew his project would be highly challenging, but it was also unique and had potential for strong impact. 

“We firmly believe that nothing that could become impactful would come easily in biomedical research,” states Dr. Horiuchi.

Two years later, his team’s research has preliminarily validated the relationship of these proteins in the proliferation of TNBC tumors.  This research, while still growing, has gained the support of a nationally recognized immuno-oncology scientist.  Dr. Horiuchi’s team now has a track record to pursue publication and federal funding.  Most importantly, they will continue this line of investigation to establish the S100 proteins as novel immuno-oncology targets in TNBC. 

Throughout his investigations, Dr. Horiuchi remains rooted in his ultimate goal, to reduce the mortality rate for TNBC patients.  The Lynn Sage Foundation is similarly dedicated to funding innovative breast cancer research.  And, like Dr. Horiuchi, we could not be more grateful for support of our cause.  Investing in young doctors with novel theories is not without risk, but we believe we won’t end breast cancer without supporting ambitious minds. 

Thank you for contributing to the Lynn Sage Scholars Program and bold ideas in the fight against breast cancer!

Links:

Share on Twitter Share on Facebook

Sep 24, 2019
Curious Minds on the Path to Breakthrough

By Angie Fekrat | Executive Director

Aug 2, 2019
Newlywed, Newly Diagnosed

By Angie Fekrat | Executive Director

About Project Reports

Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.

If you donate to this project or have donated to this project, you can recieve an email when this project posts a report. You can also subscribe for reports without donating.

Sign up for updates

Organization Information

Lynn Sage Breast Cancer Foundation

Location: Chicago, IL - USA
Website:
Facebook: Facebook Page
Project Leader:
Info @ Lynn Sage
Chicago , IL United States
$114,855 raised of $1,000,000 goal
 
1,629 donations
$885,145 to go
Donate Now
lock
Donating through GlobalGiving is safe, secure, and easy with many payment options to choose from. View other ways to donate

Lynn Sage Breast Cancer Foundation has earned this recognition on GlobalGiving:

Help raise money!

Support this important cause by creating a personalized fundraising page.

Start a Fundraiser

Learn more about GlobalGiving

Teenage Science Students
Vetting +
Due Diligence

Snorkeler
Our
Impact

Woman Holding a Gift Card
Give
Gift Cards

Young Girl with a Bicycle
GlobalGiving
Guarantee

Get incredible stories, promotions, and matching offers in your inbox

WARNING: Javascript is currently disabled or is not available in your browser. GlobalGiving makes extensive use of Javascript and will not function properly with Javascript disabled. Please enable Javascript and refresh this page.